首页> 外文会议>European Symposium on Metabolism >Molecular-genetics of the hypoalphalipoproteinemiasin Italy
【24h】

Molecular-genetics of the hypoalphalipoproteinemiasin Italy

机译:乳腺蛋白酶蛋白患者意大利的分子遗传学

获取原文

摘要

The molecular bases of hypoalphalipoproteinemia (HA), which is associated with premature coronary heart disease (pCAD) in most cases, were investigated in 80 Italian probands. ABCA1, Apo AIj LCAT, LPL and GBA were the candidate genes. The molecular defect was found in 64% of probands (4% ABCA1, 4% Apo AI, 11% LCAT, 44% LPL and 1% GBA mutations). Premature CAD was found in homozygotes for ABCA1 and Apo AI gene mutations and in heterozygotes who also carried other cardiovascular risk factors. In heterozygous subjects for LCAT mutations, there was no clear evidence of an increase in cardiovascular risk. A high prevalence of pCAD was found in males over 40 carrying LPL gene mutations.
机译:在大多数情况下,在大多数情况下,在大多数情况下研究了与早产冠心病(PCAD)相关的低alphalipeNop血症(HA)的分子碱。 ABCA1,APO AIJ LCAT,LPL和GBA是候选基因。分子缺陷在64%的药物中发现(4%ABCA1,4%APO Ai,11%LCAT,44%LPL和1%GBA突变)。在ABCA1和APO AI基因突变的纯合子和杂合子中发现过早CAD和也携带其他心血管危险因素的杂合子。在LCAT突变的杂合子受试者中,没有明确的证据表明心血管风险增加。在40多种携带的LPL基因突变中发现了PCAD的高患病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号